The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...
AMSBIO has announced a new PD-1 (Programmed Death) inhibitor screening assay kit for cancer research studies. Immunotherapy for the treatment of cancer is rapidly evolving from therapies that globally ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback